Parkinson’s Disease and PD Medications Have Distinct Signatures of the Gut Microbiome
By Erin M. Hill-Burns, Justine W. Debelius, James T. Morton, William T. Wissemann, Matthew R. Lewis, Zachary D. Wallen, Shyamal Das Peddada, S. Factor, E. Molho, C. Zabetian and 2 more. Movement Disorders, 2017
769 citations recorded by the source corpus.
There is mounting evidence for a connection between the gut and Parkinson's disease (PD). Dysbiosis of gut microbiota could explain several features of PD.
Subfields: Biological Psychiatry, Molecular Biology, Neurology
View Paper: https://www.semanticscholar.org/paper/4791b7dec5118fa3323ab44967e1713b746719d3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Neurology
Citations in the corpus
- Human gut microbiome: hopes, threats and promises (2018, result): “117 Indeed, a similar comparison can be made with some seminal studies published a couple of years ago, which showed differences in the compositions of the gut microbiota of type 2 diabetic and non-diabetic patients including an increase in A. muciniphila .”